179 related articles for article (PubMed ID: 21480671)
1. Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide.
Kuil J; Buckle T; Yuan H; van den Berg NS; Oishi S; Fujii N; Josephson L; van Leeuwen FW
Bioconjug Chem; 2011 May; 22(5):859-64. PubMed ID: 21480671
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and application of fluorescein- and biotin-labeled molecular probes for the chemokine receptor CXCR4.
Oishi S; Masuda R; Evans B; Ueda S; Goto Y; Ohno H; Hirasawa A; Tsujimoto G; Wang Z; Peiper SC; Naito T; Kodama E; Matsuoka M; Fujii N
Chembiochem; 2008 May; 9(7):1154-8. PubMed ID: 18412193
[TBL] [Abstract][Full Text] [Related]
3. Hybrid Imaging Labels: Providing the Link Between Mass Spectrometry-Based Molecular Pathology and Theranostics.
Buckle T; van der Wal S; van Malderen SJ; Müller L; Kuil J; van Unen V; Peters RJ; van Bemmel ME; McDonnell LA; Velders AH; Koning F; Vanhaeke F; van Leeuwen FW
Theranostics; 2017; 7(3):624-633. PubMed ID: 28255355
[TBL] [Abstract][Full Text] [Related]
4. Concise site-specific synthesis of DTPA-peptide conjugates: application to imaging probes for the chemokine receptor CXCR4.
Masuda R; Oishi S; Ohno H; Kimura H; Saji H; Fujii N
Bioorg Med Chem; 2011 May; 19(10):3216-20. PubMed ID: 21524584
[TBL] [Abstract][Full Text] [Related]
5. High-resolution imaging and single-cell analysis via laser ablation-inductively coupled plasma-mass spectrometry for the determination of membranous receptor expression levels in breast cancer cell lines using receptor-specific hybrid tracers.
Van Acker T; Buckle T; Van Malderen SJM; van Willigen DM; van Unen V; van Leeuwen FWB; Vanhaecke F
Anal Chim Acta; 2019 Oct; 1074():43-53. PubMed ID: 31159938
[TBL] [Abstract][Full Text] [Related]
6. Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression.
Kuil J; Buckle T; Oldenburg J; Yuan H; Borowsky AD; Josephson L; van Leeuwen FW
Mol Pharm; 2011 Dec; 8(6):2444-53. PubMed ID: 22085282
[TBL] [Abstract][Full Text] [Related]
7. Development of a 111In-labeled peptide derivative targeting a chemokine receptor, CXCR4, for imaging tumors.
Hanaoka H; Mukai T; Tamamura H; Mori T; Ishino S; Ogawa K; Iida Y; Doi R; Fujii N; Saji H
Nucl Med Biol; 2006 May; 33(4):489-94. PubMed ID: 16720240
[TBL] [Abstract][Full Text] [Related]
8. Peptide-functionalized luminescent iridium complexes for lifetime imaging of CXCR4 expression.
Kuil J; Steunenberg P; Chin PT; Oldenburg J; Jalink K; Velders AH; van Leeuwen FW
Chembiochem; 2011 Aug; 12(12):1897-903. PubMed ID: 21739561
[TBL] [Abstract][Full Text] [Related]
9. Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS.
Buckle T; Kuil J; van den Berg NS; Bunschoten A; Lamb HJ; Yuan H; Josephson L; Jonkers J; Borowsky AD; van Leeuwen FW
PLoS One; 2013; 8(1):e48324. PubMed ID: 23326303
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma.
Sand LGL; Buckle T; van Leeuwen FWB; Corver WE; Kruisselbrink AB; Jochemsen AG; Hogendoorn PCW; Szuhai K
BMC Cancer; 2017 May; 17(1):383. PubMed ID: 28549419
[TBL] [Abstract][Full Text] [Related]
11. Novel bioactive and stable neurotensin peptide analogues capable of delivering radiopharmaceuticals and molecular beacons to tumors.
Achilefu S; Srinivasan A; Schmidt MA; Jimenez HN; Bugaj JE; Erion JL
J Med Chem; 2003 Jul; 46(15):3403-11. PubMed ID: 12852770
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and characterization of a dual modality positron emission tomography and fluorescence imaging agent for monoclonal antibody tumor-targeted imaging.
Xu H; Baidoo K; Gunn AJ; Boswell CA; Milenic DE; Choyke PL; Brechbiel MW
J Med Chem; 2007 Sep; 50(19):4759-65. PubMed ID: 17725340
[TBL] [Abstract][Full Text] [Related]
13. Development and application of fluorescent SDF-1 derivatives.
Masuda R; Oishi S; Tanahara N; Ohno H; Hirasawa A; Tsujimoto G; Kodama E; Matsuoka M; Fujii N
Future Med Chem; 2012 May; 4(7):837-44. PubMed ID: 22571609
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent and lanthanide labeling for ligand screens, assays, and imaging.
Josan JS; De Silva CR; Yoo B; Lynch RM; Pagel MD; Vagner J; Hruby VJ
Methods Mol Biol; 2011; 716():89-126. PubMed ID: 21318902
[TBL] [Abstract][Full Text] [Related]
15. Amine-reactive forms of a luminescent diethylenetriaminepentaacetic acid chelate of terbium and europium: attachment to DNA and energy transfer measurements.
Li M; Selvin PR
Bioconjug Chem; 1997; 8(2):127-32. PubMed ID: 9095352
[TBL] [Abstract][Full Text] [Related]
16. Site-specific conjugation of a lanthanide chelator and its effects on the chemical synthesis and receptor binding affinity of human relaxin-2 hormone.
Shabanpoor F; Bathgate RA; Belgi A; Chan LJ; Nair VB; Wade JD; Hossain MA
Biochem Biophys Res Commun; 2012 Apr; 420(2):253-6. PubMed ID: 22425984
[TBL] [Abstract][Full Text] [Related]
17. An innovative approach for the synthesis of dual modality peptide imaging probes based on the native chemical ligation approach.
Hawala I; De Rosa L; Aime S; D'Andrea LD
Chem Commun (Camb); 2020 Mar; 56(24):3500-3503. PubMed ID: 32101189
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of N(alpha)-Boc-N(epsilon)-tetrabenzyl-DTPA-L-lysine and N(alpha)-Fmoc-N(epsilon)-tetra-t-butyl-DTPA-L-lysine, building blocks for solid phase synthesis of DTPA-containing peptides.
Davies JS; Al-Jamri L
J Pept Sci; 2002 Dec; 8(12):663-70. PubMed ID: 12523643
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of a
Mikaeili A; Erfani M; Sabzevari O
Nucl Med Biol; 2017 Nov; 54():10-17. PubMed ID: 28810154
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
